ArticleArchives of microbiology2026
Computational examination of magainin-I-KL mediated disruption of E. coli biofilms via CsgA amyloid interference.
Article in Archives of microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The adhesion of bacterial cells through extracellular matrices plays a critical role in biofilm formation. Disrupting these matrices offers a promising strategy to overcome the persistent challenge of eradicating biofilms associated with chronic infections. CsgA, a major functional amyloid within the extracellular matrix of Escherichia coli (E. coli), adopts a β-sheet-rich conformation that contributes to the structural integrity of biofilms. The stability of these β-sheets is maintained by an extensive hydrogen-bonding network within the protein, and their disruption can compromise biofilm viability. In this study, computational approaches were employed to identify anti-biofilm peptides capable of targeting the β-sheet structures of CsgA amyloid. Among 41 screened peptides, 10 were predicted to be toxic, and the remaining 31 were subjected to molecular docking and reactivity analyses. The HOMO-LUMO energy gap was evaluated before and after docking to assess peptide reactivity, identifying 22 peptides with high reactivity for further dynamic simulations using discrete molecular dynamics. Comparative analyses revealed that Brevinin-1BW, Kassinatuerin-3, Ranateurin-2Awa, Temporin-B, and Magainin-I-KL decreased the β-sheet content of CsgA relative to the untreated protein. Notably, Magainin-I-KL induced a 7% reduction in β-sheet content and substantial structural disruption, as evidenced by decreased hydrogen bonding, increased metastable states in the free-energy landscape, and deformation patterns in cross-correlation analysis. Steered molecular dynamics simulations further demonstrated that Magainin-I-KL exhibited greater resistance to force-induced dissociation, indicating stronger interactions with CsgA. Overall, Magainin-I-KL effectively destabilizes the CsgA amyloid structure of E. coli, suggesting its potential as a lead peptide for disrupting amyloid-based biofilm formation and enhancing antimicrobial strategies.
Indexed as
Identifiers
41724836What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.